132 related articles for article (PubMed ID: 20713251)
1. Adjuvant systems educational supplement. Introductory editorial.
Spier R
Vaccine; 2010 Aug; 28 Suppl 3():C1. PubMed ID: 20713251
[No Abstract] [Full Text] [Related]
2. Preformulation studies--The next advance in aluminum adjuvant-containing vaccines.
Hem SL; HogenEsch H; Middaugh CR; Volkin DB
Vaccine; 2010 Jul; 28(31):4868-70. PubMed ID: 20488265
[No Abstract] [Full Text] [Related]
3. Principles of vaccine design-Lessons from nature.
Zepp F
Vaccine; 2010 Aug; 28 Suppl 3():C14-24. PubMed ID: 20713252
[TBL] [Abstract][Full Text] [Related]
4. Editorial (Thematic Issue: Immune Modulation).
De Sanctis JB
Curr Pharm Des; 2016; 22(41):6207-6208. PubMed ID: 28164763
[No Abstract] [Full Text] [Related]
5. Immune selection, senescence and adjuvant.
Tang H
Sci China Life Sci; 2013 May; 56(5):391. PubMed ID: 23633069
[No Abstract] [Full Text] [Related]
6. How do adjuvants work? Important considerations for new generation adjuvants.
McKee AS; Munks MW; Marrack P
Immunity; 2007 Nov; 27(5):687-90. PubMed ID: 18031690
[TBL] [Abstract][Full Text] [Related]
7. From 'perfect mix' to 'potion magique'-- regulatory T cells and anti-inflammatory cytokines as adjuvant targets.
Bayry J; Flower DR; Tough DF; Kaveri SV
Nat Rev Microbiol; 2008 Jan; 6(1):C1; author reply C2. PubMed ID: 18087776
[No Abstract] [Full Text] [Related]
8. [The immunologic basis of vaccination. Hightech training for the immune system].
Zündorf I; Vollmar AM; Dingermann T
Pharm Unserer Zeit; 2008; 37(1):20-7. PubMed ID: 18081075
[No Abstract] [Full Text] [Related]
9. Engagement of TLR signaling as adjuvant: towards smarter vaccine and beyond.
Lahiri A; Das P; Chakravortty D
Vaccine; 2008 Dec; 26(52):6777-83. PubMed ID: 18835576
[TBL] [Abstract][Full Text] [Related]
10. Unmet needs in modern vaccinology: adjuvants to improve the immune response.
Leroux-Roels G
Vaccine; 2010 Aug; 28 Suppl 3():C25-36. PubMed ID: 20713254
[TBL] [Abstract][Full Text] [Related]
11. Immunology: dangerous liaisons.
Heath WR; Carbone FR
Nature; 2003 Oct; 425(6957):460-1. PubMed ID: 14523425
[No Abstract] [Full Text] [Related]
12. Adjuvant activities of saponins from traditional Chinese medicinal herbs.
Song X; Hu S
Vaccine; 2009 Aug; 27(36):4883-90. PubMed ID: 19559122
[TBL] [Abstract][Full Text] [Related]
13. ISCOMATRIX adjuvant: a potent inducer of humoral and cellular immune responses.
Pearse MJ; Drane D
Vaccine; 2004 Jun; 22(19):2391-5. PubMed ID: 15193400
[TBL] [Abstract][Full Text] [Related]
14. Adjuvants for immunotherapy: lost in translation?
van Hemelen D; van Oosterhout AJ
Clin Exp Allergy; 2009 Dec; 39(12):1783-5. PubMed ID: 20085594
[No Abstract] [Full Text] [Related]
15. A purinergic hypothesis for immunomodulation.
Di Virgilio F; Mutini C; Chiozzi P; Falzoni S; Di Susino M; Sanz JM; Ferrari D
Ital J Biochem; 1996 Dec; 45(4):195-203. PubMed ID: 9154165
[No Abstract] [Full Text] [Related]
16. [Vitamins and immune system: vitamin E].
Pletsitył KD
Vopr Pitan; 1997; (4):9-12. PubMed ID: 9412082
[No Abstract] [Full Text] [Related]
17. Future prospects for vaccine adjuvants.
Warren HS; Chedid LA
Crit Rev Immunol; 1988; 8(2):83-101. PubMed ID: 3276445
[TBL] [Abstract][Full Text] [Related]
18. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
[TBL] [Abstract][Full Text] [Related]
19. An aluminium adjuvant in a vaccine is an acute exposure to aluminium.
Exley C
J Trace Elem Med Biol; 2020 Jan; 57():57-59. PubMed ID: 31561170
[No Abstract] [Full Text] [Related]
20. Vaccine immunopotentiators of the future.
Schijns VE; Degen WG
Clin Pharmacol Ther; 2007 Dec; 82(6):750-5. PubMed ID: 17914440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
